Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for SomaLogic, Inc. (SLGC : NSDQ)
 
 • Company Description   
SomaLogic Inc. provides AI-data driven proteomics technology. SomaLogic Inc., formerly known as CM Life Sciences II Inc., is based in NEW YORK.

Number of Employees: 320

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.21 Daily Weekly Monthly
20 Day Moving Average: 971,362 shares
Shares Outstanding: 183.45 (millions)
Market Capitalization: $405.43 (millions)
Beta: 1.88
52 Week High: $8.50
52 Week Low: $2.02
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -28.48% -26.17%
12 Week -6.36% -8.89%
Year To Date -11.95% -14.45%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2945 WILDERNESS PLACE
-
BOULDER,CO 80301
USA
ph: 303-625-9000
fax: -
investors@somalogic.com http://www.somalogic.com
 
 • General Corporate Information   
Officers
Roy Smythe - Chief Executive Officer
Shaun Blakeman - Chief Financial Officer
Robert Barchi - Director
Eli Casdin - Director
Troy Cox - Director

Peer Information
SomaLogic, Inc. (EVOL)
SomaLogic, Inc. (RAMP)
SomaLogic, Inc. (ALOT)
SomaLogic, Inc. (TGHI)
SomaLogic, Inc. (GNCMA)
SomaLogic, Inc. (GSIC)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Technology Services
Sector: Business Services
CUSIP: 83444K105
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/22
Next Expected EPS Date: 03/28/23
Share - Related Items
Shares Outstanding: 183.45
Most Recent Split Date: (:1)
Beta: 1.88
Market Capitalization: $405.43 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.43 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 03/28/23  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.67
Price/Cash Flow: -
Price / Sales: 3.98
EPS Growth
vs. Year Ago Period: 45.45%
vs. Previous Quarter: -38.46%
Sales Growth
vs. Year Ago Period: 108.65%
vs. Previous Quarter: 194.92%
ROE
12/31/22 - -
09/30/22 - -18.23
06/30/22 - -16.76
ROA
12/31/22 - -
09/30/22 - -15.92
06/30/22 - -14.61
Current Ratio
12/31/22 - -
09/30/22 - 14.56
06/30/22 - 18.86
Quick Ratio
12/31/22 - -
09/30/22 - 14.12
06/30/22 - 18.26
Operating Margin
12/31/22 - -
09/30/22 - -109.16
06/30/22 - -128.78
Net Margin
12/31/22 - -
09/30/22 - -81.72
06/30/22 - -114.46
Pre-Tax Margin
12/31/22 - -
09/30/22 - -82.33
06/30/22 - -114.46
Book Value
12/31/22 - -
09/30/22 - 3.29
06/30/22 - 3.31
Inventory Turnover
12/31/22 - -
09/30/22 - 2.53
06/30/22 - 2.67
Debt-to-Equity
12/31/22 - -
09/30/22 - 0.00
06/30/22 - 0.00
Debt-to-Capital
12/31/22 - -
09/30/22 - 0.00
06/30/22 - 0.00
 

Powered by Zacks Investment Research ©